Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Samsung Epis Holdings (0126Z0.KS) News - StockMarketCap

Stocks›Samsung Epis Holdings☆

● At closeAs of Jul 3, 2026

Samsung Epis Holdings

KRX: 0126Z0✓

HealthcareBiotechnologyKSC

$266.37₩411,000.00-0.72%

$6.63BMarket cap

-P/E ratio

17.99KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$266.37₩411,000.00

-$1.94 (-0.72%) · 24h

Key metrics

Market cap$6.63B-13.58%

Enterprise value$6.63B

Volume (24h)17.99K

P/E ratio (TTM)-

P/S ratio (TTM)-

Dividend yield-

Shares outstanding24.88M

Trading range

Previous close₩414,000.00

Day range₩404,500.00 - ₩424,500.00

52-week range-

Samsung Epis Holdings (0126Z0.KS) operates in the Biotechnology industry within the Healthcare sector, listed on KSC.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news